HEALTH CARE SERVICE CORPORATION, A MUTUAL LEGAL RESERVE COMPANY (HCSC) for HEALTH CARE SERVICE CORPORATION, A MUTUAL LEGAL RESERVE COMPANY (HCSC)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 21, 2020 | $1,100,000 | Replaced |
| 4th Quarter - Amendment (this page) | Feb 28, 2020 | $1,100,000 | Replaced |
| 4th Quarter - Amendment | Dec 17, 2020 | $1,350,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 7217 - IMPROVE Act: Issues pertaining to Part D rebates; 2020 Notice of Benefit and Payment Parameters, Money Follows the Person, Medicaid Medical Loss Ratio.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA DOYLE | — |
| DANIEL R. JONES | — |
| JERRY STEFFL | — |
Health Issues HCR
H.R. 965, S. 340 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019: Issues regarding processes by which generic manufacturers can obtain sufficient quantities of brand drug samples for testing. H.R. 3253 - Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019: Regarding all provisions. S. 1895 - The Lower Health Care Costs Act: Issues related to rural health access; health equity; Medicare Advantage; Medicaid Rebates; Medicaid Expansion; Rate Notice and Call Letter; Medicare Part D; NBPP, Part D Donut Hole; Privacy; Universal Coverage. H.R. 259, Medicaid Extenders Act of 2019, H.R. 4378, Continuing Appropriations Act of 2020: Issues related to Medicaid extension. HR 1398, S. 172 - Health Insurance Tax Relief Act of 2019, S. 80 - Jobs and Premium Protection Act; Issues related to repeal and delay the health insurer fee. Issues related to the Affordable Care Act reinsurance/stabilization. H.R. 861 - End Surprise Billing Act, HR 3630 - No Surprises Act, H.R. 3502 - Protecting People from Surprise Medical Bills Act; Issues relating to surprise billing, including benchmark payments, arbitration models, and out of network billing. S. 916 - MOMMAs Act, H.R. 2602, S. 1343 - MOMMIES Act, HR 4996 - Helping Medicaid Offer Maternity Services Act of 2019: Issues related to options for states to extend coverage for pregnant women eligible for Medicaid via the pregnancy pathway to 365 days, Minority Maternity Care, Social Determinants of Health. S. 657 - Drug Price Transparency (DPT) Act, S. 2543 - Prescription Drug Pricing Reduction Act of 2019: Issues relating to drug and price transparency. H.R. 3- Lower Drug Costs Now Act of 2019, S. 102 - Prescription Drug Pricing Reduction Act of 2019: Issues relating to drug costs and prescription rebates. Issues relating to drug and price transparency, including the Administrations rule on interoperability and Executive order on transparency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA DOYLE | — |
| DANIEL R. JONES | — |
| JERRY STEFFL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.